ArticleInternational urology and nephrology2025

Elevated lipoprotein-associated phospholipase A2 as a biomarker for cognitive impairment in chronic kidney disease.

Sujuan Feng et al.PubMed ↗Publisher ↗

No numbers read from the abstract.